Harel Insurance Investments & Financial Services Ltd.
InsurancePosition in INCY — Incyte Corp
CIK 1429390
Ramat Gan, L3
Position in INCY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$416,031
-$2,272,359 QoQ
Shares Held
3,670
-89.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#556
of 854 holders
Holding Since
Sep 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Harel Insurance Investments & Financial Services Ltd. holds $5,070,384 across 6 Biotechnology names. INCY ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,837 | $1,905,953 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,822 | $1,759,629 | |
| 3 | EXEL |
Exelixis, Inc.
|
16,890 | $918,984 | |
| 4 | INCY |
Incyte Corp
This page
|
3,670 | $416,031 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
1,550 | $53,196 | |
| 6 | CAPR |
Capricor Therapeutics, Inc.
|
689 | $16,591 |
All Filings in INCY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $416,031 | 3,670 | Shares | Defined | 2026-07-29 | |
| 2022-12-31 | $2,688,390 | 33,471 | Shares | Defined | 2023-01-26 | |
| 2022-09-30 | $2,196,720 | 32,964 | Shares | Defined | 2022-10-31 | |
| 2020-12-31 | $153,780 | 1,768 | Shares | Defined | 2021-01-26 | |
| 2020-09-30 | $158,660 | 1,768 | Shares | Defined | 2020-10-20 | |
| No filing history on record for this holder in this stock. | ||||||